Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Working Capital Changes (2016 - 2025)

Nephros (NEPH) has 16 years of Other Working Capital Changes data on record, last reported at $162000.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 25.0% year-over-year to $162000.0; the TTM value through Sep 2025 reached -$412000.0, down 384.14%, while the annual FY2024 figure was -$442000.0, 689.29% down from the prior year.
  • Other Working Capital Changes reached $162000.0 in Q3 2025 per NEPH's latest filing, up from -$84000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $243000.0 in Q4 2022 and bottomed at -$406000.0 in Q4 2024.
  • Average Other Working Capital Changes over 5 years is -$45368.4, with a median of -$84000.0 recorded in 2025.
  • Peak YoY movement for Other Working Capital Changes: tumbled 520.0% in 2022, then soared 380.52% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at -$159000.0 in 2021, then skyrocketed by 252.83% to $243000.0 in 2022, then dropped by 25.51% to $181000.0 in 2023, then tumbled by 324.31% to -$406000.0 in 2024, then surged by 139.9% to $162000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $162000.0 in Q3 2025, -$84000.0 in Q2 2025, and -$84000.0 in Q1 2025.